Trade names or approved names. Part III. Special cases. Clinical trials
- PMID: 4465771
- PMCID: PMC2495491
- DOI: 10.1136/pgmj.50.580.114
Trade names or approved names. Part III. Special cases. Clinical trials
Abstract
The choice of standard drugs to be used in clinical trials must be based on consideration of human absorption data, in vitro characteristics, possible interactions, comparative efficacy and safety, previous data regarding the standard in relation to the syndrome to be studied, and correlation of blood levels, effectiveness and safety.
